These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39140692)

  • 1. Crystal structure of dihydroneopterin aldolase from
    Czeczot AM; Muniz MN; Perelló MA; Silva ÉED; Timmers LFSM; Berger A; Gonzalez LC; Arraché Gonçalves G; Moura S; Machado P; Bizarro CV; Basso LA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2388207. PubMed ID: 39140692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Mercaptoguanine-based inhibitors of
    Czeczot AM; Roth CD; Ducati RG; Pissinate K; Rambo RS; Timmers LFSM; Abbadi BL; Macchi FS; Pestana VZ; Basso LA; Machado P; Bizarro CV
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):847-855. PubMed ID: 33752554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug development.
    Falcão VC; Villela AD; Rodrigues-Junior VS; Pissinate K; Eichler P; Pinto AF; Basso LA; Santos DS; Bizarro CV
    Biochem Biophys Res Commun; 2017 Apr; 485(4):814-819. PubMed ID: 28257847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
    Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
    Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
    Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
    J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acyl phenothiazines as mycobacterial ATP synthase inhibitors: Rational design, synthesis and in vitro evaluation against drug sensitive, RR and MDR-TB.
    Reddyrajula R; Perveen S; Negi A; Etikyala U; Manga V; Sharma R; Dalimba UK
    Bioorg Chem; 2024 Oct; 151():107702. PubMed ID: 39142196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
    Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
    Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First triclosan-based macrocyclic inhibitors of InhA enzyme.
    Rodriguez F; Saffon N; Sammartino JC; Degiacomi G; Pasca MR; Lherbet C
    Bioorg Chem; 2020 Jan; 95():103498. PubMed ID: 31855823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
    Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
    Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
    Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
    Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Structure-Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH.
    Singh V; Pacitto A; Donini S; Ferraris DM; Boros S; Illyés E; Szokol B; Rizzi M; Blundell TL; Ascher DB; Pato J; Mizrahi V
    Eur J Med Chem; 2019 Jul; 174():309-329. PubMed ID: 31055147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
    Zhang W; Lun S; Liu LL; Xiao S; Duan G; Gunosewoyo H; Yang F; Tang J; Bishai WR; Yu LF
    J Med Chem; 2019 Apr; 62(7):3575-3589. PubMed ID: 30875203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling.
    Kassem AF; Sabt A; Korycka-Machala M; Shaldam MA; Kawka M; Dziadek B; Kuzioła M; Dziadek J; Batran RZ
    Bioorg Chem; 2024 Sep; 150():107511. PubMed ID: 38870705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.